Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Liver Cancers (eBook)

From Mechanisms to Management

Tim Cross, Daniel H. Palmer (Herausgeber)

eBook Download: PDF
2018 | 1st ed. 2019
XVI, 312 Seiten
Springer International Publishing (Verlag)
978-3-319-92216-4 (ISBN)

Lese- und Medienproben

Liver Cancers -
Systemvoraussetzungen
117,69 inkl. MwSt
(CHF 114,95)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen

This book explores in detail the primary liver cancers of hepatocellular carcinoma and cholangiocarcinoma examining the pathogenesis of disease along with diagnosis and current management options together with exploration of future treatment strategies and areas of controversy.   Furthermore, the book highlights management of the common secondary malignancies and touches on benign liver tumours and how to best manage these.  

Written in a clear and didactic style, this volume includes summaries of the key learning points and questions so that the reader can gauge their knowledge and understanding.

This book is aimed to broaden the knowledge base of primary care physicians, general physicians along with specialists in hepatology, oncology and hepato-biliary surgery



Dr Tim Cross, BMedSci (Hons), MB BS, MD, FRCP

Dr Cross qualified from St. Bartholomew's hospital medical college in 1996.  He undertook general gastroenterology training in North East London and hepatology training at Addenbrookes hospital, Cambridge, The Royal Free Hospital, University College Hospital and Kings College Hospital, London.  He was a consultant at the South West Liver Unit, Plymouth UK before moving to the Royal Liverpool Hospital in 2012.

 

Prof Daniel Palmer, BSc (Hons), MBChB, PhD, FRCP

Professor Palmer graduated from the University of Birmingham in 1995 and undertook his specialist training in Medical Oncology in the Birmingham Oncology Centre before taking the position of Cancer Research UK Clinician Scientist and Senior Lecturer, University of Liverpool. He took the North West Cancer Research Chair of Medical Oncology at the University of Liverpool in 2011. His specialist interests include development of novel therapies and clinical trials for hepatobiliary and pancreatic cancers.

Dr Tim Cross, BMedSci (Hons), MB BS, MD, FRCP Dr Cross qualified from St. Bartholomew’s hospital medical college in 1996.  He undertook general gastroenterology training in North East London and hepatology training at Addenbrookes hospital, Cambridge, The Royal Free Hospital, University College Hospital and Kings College Hospital, London.  He was a consultant at the South West Liver Unit, Plymouth UK before moving to the Royal Liverpool Hospital in 2012.   Prof Daniel Palmer, BSc (Hons), MBChB, PhD, FRCP Professor Palmer graduated from the University of Birmingham in 1995 and undertook his specialist training in Medical Oncology in the Birmingham Oncology Centre before taking the position of Cancer Research UK Clinician Scientist and Senior Lecturer, University of Liverpool. He took the North West Cancer Research Chair of Medical Oncology at the University of Liverpool in 2011. His specialist interests include development of novel therapies and clinical trials for hepatobiliary and pancreatic cancers.

Part I: Hepatocellular carcinoma (HCC).- Pathogenesis of HCC).- Surveillance for HCC.- Diagnosis of HCC.- Part II: Treatment.- Surgery.- Ablation techniques.- Transarterial chemoembolization.- Transarterial Radio-embolization.- Liver transplantation.- Chemotherapy and HCC.- Emerging novel therapies.- Part IIV: Cholangiocarcinoma.- Pathogenesis.- Diagnosis and surveillance.- Part IV:Management.- Surgery.- Ablation and embolic treatments.- Chemotherapy.- Emerging novel therapies.- Mixed Malignancies HCC/cholangiocarcinoma.- Part V: Metastatic Liver cancers.- Colorectal cancer.- Melanoma.- Neuroendocrine tumours.- Sarcomas.- Lymphoma.- Part VI: Benign Liver Tumours.- Benign Liver tumours.

Erscheint lt. Verlag 12.12.2018
Zusatzinfo XVI, 312 p. 46 illus., 34 illus. in color.
Verlagsort Cham
Sprache englisch
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Allgemeinmedizin
Medizin / Pharmazie Medizinische Fachgebiete Innere Medizin
Schlagworte benign liver tumors • Cholangiocarcinoma • hepatocellular carcinoma • hepatology • Liver Cancer • liver metastases
ISBN-10 3-319-92216-5 / 3319922165
ISBN-13 978-3-319-92216-4 / 9783319922164
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 7,1 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich